QuickView for TRIP14 (gene)

1. The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator …
2. OASL knockdown inhibits the progression of stomach adenocarcinoma by regulating the mTORC1 signaling…
3. In silico identification of potential inhibitors against human 2'-5'- oligoadenylate synthetase (OAS…
4. Length dependent activation of OAS proteins by dsRNA.
5. OASL1 Traps Viral RNAs in Stress Granules to Promote Antiviral Responses.

There were no clinical trials for TRIP14